Senior Justice Department officials in the Trump administration are mulling a weapons ban that would single out transgender Americans. The proposal would limit transgender people’s right to possess ...

The Karnataka government has exempted individual houses on 30x40 sites (1,200 sqft) within Greater Bengaluru Authority limits from needing an occupancy certificate (OC). This decision, announced ...

Changes are afoot at Boots with its new owner plotting aggressive growth after the $10 billion deal to buy its parent company was concluded. The multi-billion takeover of Walgreens Boots Alliance (WBA ...

Mark Zuckerberg’s Meta is gearing up to open its first physical store in London to boost interest in its virtual reality (VR) headsets and glasses. The social media giant, which owns Facebook, is ...

Reform UK today said it could cut £350 from annual council tax bills by shaking up local authority pension rules. Deputy leader Richard Tice used a press conference this morning to unveil plans to ...

After months of turmoil from Donald Trump’s tariff changes, e-commerce platform Temu is charging back into the U.S. market with deep discounts to regain ground against rival Shein Group. At least two ...

14:10, Tue, Sep 2, 2025 Updated: 20:42, Tue, Sep 2, 2025 Yvette Cooper thinks she's cracked the case. The Home Secretary revealed asylum seekers will now face a temporary ban on family reunions, plus ...

President Donald Trump and his top political advisers are plotting an aggressive push to oust one of his most persistent Republican adversaries: Rep. Thomas Massie. And House GOP leaders won’t stand ...

Sen. Josh Hawley says that only humans should be driving cars and trucks. He told BI on Tuesday that he plans to introduce a bill on the topic soon. He said the proliferation of driverless cars is ...

Radiohead has announced a series of European tour dates for November and December, marking their first shows in more than seven years. The art-rock giants will set up shop in various cities across the ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...